Literature DB >> 1356551

Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects.

A Nehlig1, J L Daval, G Debry.   

Abstract

Caffeine is the most widely consumed central-nervous-system stimulant. Three main mechanisms of action of caffeine on the central nervous system have been described. Mobilization of intracellular calcium and inhibition of specific phosphodiesterases only occur at high non-physiological concentrations of caffeine. The only likely mechanism of action of the methylxanthine is the antagonism at the level of adenosine receptors. Caffeine increases energy metabolism throughout the brain but decreases at the same time cerebral blood flow, inducing a relative brain hypoperfusion. Caffeine activates noradrenaline neurons and seems to affect the local release of dopamine. Many of the alerting effects of caffeine may be related to the action of the methylxanthine on serotonin neurons. The methylxanthine induces dose-response increases in locomotor activity in animals. Its psychostimulant action on man is, however, often subtle and not very easy to detect. The effects of caffeine on learning, memory, performance and coordination are rather related to the methylxanthine action on arousal, vigilance and fatigue. Caffeine exerts obvious effects on anxiety and sleep which vary according to individual sensitivity to the methylxanthine. However, children in general do not appear more sensitive to methylxanthine effects than adults. The central nervous system does not seem to develop a great tolerance to the effects of caffeine although dependence and withdrawal symptoms are reported.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356551     DOI: 10.1016/0165-0173(92)90012-b

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  232 in total

1.  The role of calcium in the desensitization of capsaicin responses in rat dorsal root ganglion neurons.

Authors:  P A Koplas; R L Rosenberg; G S Oxford
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

Review 2.  Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

Authors:  Fabio Broccatelli; Caroline A Larregieu; Gabriele Cruciani; Tudor I Oprea; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2011-12-21       Impact factor: 15.470

3.  Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.

Authors:  Bing Gong; Ottavio V Vitolo; Fabrizio Trinchese; Shumin Liu; Michael Shelanski; Ottavio Arancio
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 4.  Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.

Authors:  Faidon Magkos; Stavros A Kavouras
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

5.  Caffeine augmentation of electroconvulsive seizures.

Authors:  A Francis; L Fochtmann
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

Review 6.  Caffeine in tea Camellia sinensis--content, absorption, benefits and risks of consumption.

Authors:  A Gramza-Michałowska
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

7.  Ryanodine receptor-mediated intracellular calcium release in rat cerebellar Purkinje neurones.

Authors:  M Kano; O Garaschuk; A Verkhratsky; A Konnerth
Journal:  J Physiol       Date:  1995-08-15       Impact factor: 5.182

8.  Presynaptic adenosine A₁ receptors modulate excitatory transmission in the rat basolateral amygdala.

Authors:  Andrew R Rau; Olusegun J Ariwodola; Jeff L Weiner
Journal:  Neuropharmacology       Date:  2013-11-06       Impact factor: 5.250

9.  Effects of adolescent caffeine consumption on cocaine self-administration and reinstatement of cocaine seeking.

Authors:  Tracey A Larson; Casey E O'Neill; Michaela P Palumbo; Ryan K Bachtell
Journal:  J Psychopharmacol       Date:  2018-11-28       Impact factor: 4.153

Review 10.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.